WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: TYPE 2 DIABETES, NONPHARMACOLOGICAL SPECIFIC SMOKING CESSATION, INSULIN MAY CONSIDER INSULIN PUMP, 2 HOUR GLUCOSE TOLERANCE GREATER THAN OR EQUAL TO 200 mg/dl SCREEN ANNUALLY OBESE, PHARMACOLOGIC DIABETES SPECIFIC THIAZOLIDINESDIONES, DIABETES MELLITUS TYPE II PATIENT CONCERNS BLOOD DRAWS, SKIN INFECTION LEADS TO AMPUTATION, THIAZOLIDINESDIONES REDUCES EXCESSIVE GLUCONEOGENSIS, MEDICATIONS ORAL THIAZOLIDINESDIONES, USE OF ANTIPSYCHOTICS TRADITIONALLY CHECKED EVERY 3 MONTHS HgBA1C "A", INSULIN INTERMEDIATE 70/30, DIABETES MELLITUS TYPE II TREATMENTS NONPHARMACOLOGICAL, LESS THAN 7 REDUCES RISK OF RETINOPATHY, LDL CHOLESTEROL "C" STANDARD GOAL LDL LESS THAN 100, MEDICATIONS AFFORDABLE SECRETAGOGUES, DIABETES MELLITUS TYPE II DIAGNOSTIC METHODS FASTING BLOOD SUGAR GREATER THAN 125 mg/dl ON 2 OCCASIONS, MEDICATIONS ORAL SECRETAGOGUES, DIABETES MELLITUS TYPE II DIAGNOSTIC METHODS SIGNS OR SYMPTOMS WITH RANDOM GLUCOSE OVER 200 mg/dl, HgBA1C "A" STANDARD GOAL LESS THAN 7, HgBA1C "A" AGGRESSIVE GOAL LESS THAN 6.5, DIABETES MELLITUS TYPE II LONG TERM MICROVASCULAR RISKS NEUROPATHY